药效评价Characterization of a cannabinoid CB2 receptor-selective agonist, A-836339 [2,2,3,3-tetramethyl-cyclopropanecarboxylic acid [3-(2-methoxy-ethyl)-4,5-dimethyl-3H-thiazol-(2Z)-ylidene]-amide], using in vitro pharmacological assays, in vivo pain models,
期刊:The Journal of pharmacology and experimental therapeutics发表年份:2009作者:Betty B Yao; Gin Hsieh; Anthony V Daza; Yihong Fan; George K Grayson; Tiffany Runyan Garrison; Odile El Kouhen; Bradley A Hooker; Madhavi Pai; Erica J Wensink; Anita K Salyers; Prasant Chandran; Chang Z Zhu; Chengmin Zhong; Keith Ryther; Megan E Gall
